ScholarIQanswers from OpenAlex

Adverse Effect of Adjuvant Tamoxifen in Premenopausal Breast Cancer with <i>Cyclin D1</i> Gene Amplification

PaperCitations, authors & open-access status

Adverse Effect of Adjuvant Tamoxifen in Premenopausal Breast Cancer with <i>Cyclin D1</i> Gene Amplification is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Adverse Effect of Adjuvant Tamoxifen in Premenopausal Breast Cancer with <i>Cyclin D1</i> Gene Amplification have?

ScholarIQcitation count

Adverse Effect of Adjuvant Tamoxifen in Premenopausal Breast Cancer with <i>Cyclin D1</i> Gene Amplification has 134 citations in the OpenAlex counts ScholarIQ stores.

When was Adverse Effect of Adjuvant Tamoxifen in Premenopausal Breast Cancer with <i>Cyclin D1</i> Gene Amplification published?

ScholarIQyear

Adverse Effect of Adjuvant Tamoxifen in Premenopausal Breast Cancer with <i>Cyclin D1</i> Gene Amplification has 2005 year in the ScholarIQ index.

What is the open-access status of Adverse Effect of Adjuvant Tamoxifen in Premenopausal Breast Cancer with <i>Cyclin D1</i> Gene Amplification?

ScholarIQoa status

Adverse Effect of Adjuvant Tamoxifen in Premenopausal Breast Cancer with <i>Cyclin D1</i> Gene Amplification has closed oa status in the ScholarIQ index.

What is the DOI of Adverse Effect of Adjuvant Tamoxifen in Premenopausal Breast Cancer with <i>Cyclin D1</i> Gene Amplification?

ScholarIQdoi

The DOI for Adverse Effect of Adjuvant Tamoxifen in Premenopausal Breast Cancer with <i>Cyclin D1</i> Gene Amplification is on the source record.

What is the PMID of Adverse Effect of Adjuvant Tamoxifen in Premenopausal Breast Cancer with <i>Cyclin D1</i> Gene Amplification?

ScholarIQpmid

The PMID for Adverse Effect of Adjuvant Tamoxifen in Premenopausal Breast Cancer with <i>Cyclin D1</i> Gene Amplification is on the source record.

What is the OpenAlex record for Adverse Effect of Adjuvant Tamoxifen in Premenopausal Breast Cancer with <i>Cyclin D1</i> Gene Amplification?

ScholarIQopenalex

The OpenAlex for Adverse Effect of Adjuvant Tamoxifen in Premenopausal Breast Cancer with <i>Cyclin D1</i> Gene Amplification is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial